Immunotech Laboratories, Inc. (IMMB)
IMMB Stock Price Chart
Explore Immunotech Laboratories, Inc. interactive price chart. Choose custom timeframes to analyze IMMB price movements and trends.
IMMB Company Profile
Discover essential business fundamentals and corporate details for Immunotech Laboratories, Inc. (IMMB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
1 Dec 2022
Employees
4.00
Website
https://www.immunotechlab.comCEO
Harry H. Zhabilov Jr., BSc, McS Science
Description
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Eco-Petroleum Solutions, Inc.
IMMB Financial Timeline
Browse a chronological timeline of Immunotech Laboratories, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
IMMB Stock Performance
Access detailed IMMB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.